CapsulesClinical Overview
Molnupiravir is an orally bioavailable prodrug of the synthetic ribonucleoside derivative N4-hydroxycytidine (NHC). In viral replication, viral RNA-dependent RNA polymerase misincorporates NHC triphosphate instead of cytidine or uridine, inducing widespread viral error catastrophe and rendering the virus unable to replicate. Indicated for the treatment of mild-to-moderate COVID-19 in adult patients at high risk for progression to severe disease, hospitalization, or death.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Swallow 800 mg (four 200 mg capsules) orally every 12 hours for 5 consecutive days, with or without food. Swallow capsules whole; do not open, break, or crush. Initiation must occur as soon as possible after diagnosis of COVID-19 and within 5 days of symptom onset.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Diarrhea, nausea, dizziness, headache. Rare/Severe: Severe hypersensitivity reactions, angioedema, potential bone/cartilage toxicity in growing individuals.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated during pregnancy: embryo-fetal toxicity risk. Females of childbearing potential must use reliable contraception during treatment and for 4 days after the final dose; males must use contraception for at least 3 months after the final dose. Not authorized for use in patients under 18 years of age due to effects on bone growth.
Schedule H1 (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.